Prestige Consumer Healthcare (PBH) Cost of Revenue (2010 - 2025)

Prestige Consumer Healthcare has reported Cost of Revenue for 16 years, with the latest figure at $126.1 million in Q4 2025.

• On a quarterly basis, Cost of Revenue fell 2.47% year-over-year to $126.1 million in Q4 2025; TTM through Dec 2025 was $484.3 million, a 3.52% decrease from a year earlier, with the FY2025 full-year figure at $503.3 million, changed 0.48% from the prior year.
• Cost of Revenue was $126.1 million for Q4 2025 at Prestige Consumer Healthcare, up from $122.5 million in the prior quarter.
• The five-year high for Cost of Revenue was $132.1 million in Q1 2023, with the low at $100.7 million in Q1 2021.
• Average Cost of Revenue over 5 years is $121.6 million, with a median of $124.7 million recorded in 2023.
• The sharpest annual moves came in 2021 and 2025: Cost of Revenue rose 19.53% in 2021, then fell 9.84% in 2025.
• Over 5 years, Cost of Revenue stood at $119.4 million in 2021, then grew by 4.78% to $125.1 million in 2022, then fell by 0.25% to $124.8 million in 2023, then climbed by 3.58% to $129.3 million in 2024, then declined by 2.47% to $126.1 million in 2025.
• The last three Cost of Revenue figures came in at $126.1 million (Q4 2025), $122.5 million (Q3 2025), and $109.2 million (Q2 2025), per Business Quant data.